Old Web
English
Sign In
Acemap
>
authorDetail
>
Steven Stylian
Steven Stylian
Royal Brisbane and Women's Hospital
Immunology
Medicine
Imatinib
Oncology
Internal medicine
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Stress erythropoiesis in hereditary spherocytosis
2020
American Journal of Hematology
Anne Haughton
Steven Stylian
Barbara J. Bain
Show All
Source
Cite
Save
Citations (0)
57: Outcomes for allogeneic transplantation in imatinib-refractory chronic myeloid leukaemia (CML) are equivalent to outcomes in imatinib-responsive/imatinib-naive CML and can be predicted by the EBMT risk score
2007
Biology of Blood and Marrow Transplantation
Simon Durrant
Steven Stylian
Robyn Western
James Morton
Jason Butler
Cheryl Hutchins
Geoffrey R. Hill
Glen A. Kennedy
Show All
Source
Cite
Save
Citations (1)
Significant Reduction of BCR-ABL Transcripts after Switching to Imatinib Therapy in Patients with CML and Complete or Near-Complete Cytogenetic Responses to Interferon-Alpha (IFN).
2006
Blood
Susan Branford
Timothy P. Hughes
Steven Stylian
Anthony P. Schwarer
Christopher Arthur
Robin Filshie
Susan Moreton
Robyn Rodwell
Nancy Guzzo-Pernell
Deb Taylor
Jenny Larson
Rachel Koelmayer
Alvin Milner
Kevin G. Lynch
Kerry McDonald Taylor
Show All
Source
Cite
Save
Citations (1)
Allogeneic Transplant Outcomes in Imatinib-Refractory Chronic Myeloid Leukaemia (CML) Are Similar to Transplant Outcomes in Imatinib-Responsive/Imatinib-Naïve CML and Appear To Be Predicted by the EBMT Risk Score.
2006
Blood
Steven Stylian
Eileen T. Fennelly
Jason Butler
James Morton
Robyn Western
Cheryl Hutchins
Geoff Hill
Simon Durrant
Glen A. Kennedy
Show All
Source
Cite
Save
Citations (0)
1